| |
|
|
| Registros recuperados : 1 | |
| 1. |  | MADRID, R. R. M; MATHEWS, P. D.; PATTA, A. C. F.; GONZALES-FLORES, A. P.; RAMIREZ. C. A. B.; RIGONI, V. L. S.; TAVARES-DIAS, M.; MERTINS, O. Safety of oral administration of high doses of ivermectin by means of biocompatible polyelectrolytes formulation. Heliyon, v. 7, n. 1, e05820, Jan. 2021.| Biblioteca(s): Embrapa Amapá. |
|    |
| Registros recuperados : 1 | |
|
|
|
Registro Completo
|
Biblioteca(s): |
Embrapa Amapá. |
|
Data corrente: |
22/09/2022 |
|
Data da última atualização: |
14/12/2022 |
|
Tipo da produção científica: |
Artigo em Periódico Indexado |
|
Circulação/Nível: |
A - 4 |
|
Autoria: |
MADRID, R. R. M; MATHEWS, P. D.; PATTA, A. C. F.; GONZALES-FLORES, A. P.; RAMIREZ. C. A. B.; RIGONI, V. L. S.; TAVARES-DIAS, M.; MERTINS, O. |
|
Afiliação: |
RAFAEL R. M. MADRID, UNIVERSIDADE FEDERAL DE SÃO PAULO; PATRICK D. MATHEWS, UNIVERSIDADE FEDERAL DE SÃO PAULO; ANA C. M. F. PATTA, UNIVERSIDADE FEDERAL DE SÃO PAULO; ANAI P. GONZALES-FLORES, INSTITUTE OF RESEARCH OF THE PERUVIAN AMAZON; CARLOS A. B. RAMIREZ, UNIVERSIDADE FEDERAL DE SÃO PAULO; VERA L. S. RIGONI, UNIVERSIDADE FEDERAL DE SÃO PAULO; MARCOS TAVARES DIAS, CPAF-AP; OMAR MERTINS, UNIVERSIDADE FEDERAL DE SÃO PAULO. |
|
Título: |
Safety of oral administration of high doses of ivermectin by means of biocompatible polyelectrolytes formulation. |
|
Ano de publicação: |
2021 |
|
Fonte/Imprenta: |
Heliyon, v. 7, n. 1, e05820, Jan. 2021. |
|
DOI: |
https://doi.org/10.1016/j.heliyon.2020.e05820 |
|
Idioma: |
Inglês |
|
Conteúdo: |
The FDA-approved drug ivermectin is applied for treatments of onchocerciasis and lymphatic filariasis. The anticancer and anti-viral activities have been demonstrated stressing possibilities for the drug repurposing and therefore new information on high dosage safety is on demand. We analyzed in vivo tissue responses for high doses of ivermectin using Corydoras fish as animal model. We made intestinal histology and hematologic assays after oral administration of ivermectin transported with polyelectrolytes formulation. Histology showed any apparent damage of intestinal tissues at 0.22?170 mg of ivermectin/kg body weight. Immunofluorescence evidenced delocalization of Myosin-Vb at enterocytes only for the higher dose. Hematology parameters showed random variations after 7 days from administration, but a later apparent recover after 14 and 21 days. The study evaluated the potential of high doses of oral administration of ivermectin formulation, which could be an alternative with benefits in high compliance therapies. |
|
Thesagro: |
Peixe. |
|
Thesaurus NAL: |
Corydoras; Ivermectin. |
|
Categoria do assunto: |
G Melhoramento Genético |
|
URL: |
https://ainfo.cnptia.embrapa.br/digital/bitstream/doc/1146721/1/CPAF-AP-2022-Safety-of-oral-administration-of-high-doses-of-ivermectin.pdf
|
|
Marc: |
LEADER 01803naa a2200253 a 4500
001 2146721
005 2022-12-14
008 2021 bl uuuu u00u1 u #d
024 7 $ahttps://doi.org/10.1016/j.heliyon.2020.e05820$2DOI
100 1 $aMADRID, R. R. M
245 $aSafety of oral administration of high doses of ivermectin by means of biocompatible polyelectrolytes formulation.$h[electronic resource]
260 $c2021
520 $aThe FDA-approved drug ivermectin is applied for treatments of onchocerciasis and lymphatic filariasis. The anticancer and anti-viral activities have been demonstrated stressing possibilities for the drug repurposing and therefore new information on high dosage safety is on demand. We analyzed in vivo tissue responses for high doses of ivermectin using Corydoras fish as animal model. We made intestinal histology and hematologic assays after oral administration of ivermectin transported with polyelectrolytes formulation. Histology showed any apparent damage of intestinal tissues at 0.22?170 mg of ivermectin/kg body weight. Immunofluorescence evidenced delocalization of Myosin-Vb at enterocytes only for the higher dose. Hematology parameters showed random variations after 7 days from administration, but a later apparent recover after 14 and 21 days. The study evaluated the potential of high doses of oral administration of ivermectin formulation, which could be an alternative with benefits in high compliance therapies.
650 $aCorydoras
650 $aIvermectin
650 $aPeixe
700 1 $aMATHEWS, P. D.
700 1 $aPATTA, A. C. F.
700 1 $aGONZALES-FLORES, A. P.
700 1 $aRAMIREZ. C. A. B.
700 1 $aRIGONI, V. L. S.
700 1 $aTAVARES-DIAS, M.
700 1 $aMERTINS, O.
773 $tHeliyon$gv. 7, n. 1, e05820, Jan. 2021.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Amapá (CPAF-AP) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
Fechar
|
| Nenhum registro encontrado para a expressão de busca informada. |
|
|
